Back to Search
Start Over
Isis, TargeGen Set Sights on Eye Treatments.
- Source :
- San Diego Business Journal; 7/17/2006, Vol. 27 Issue 29, p1-18, 2p
- Publication Year :
- 2006
-
Abstract
- The article reports that San Diego, California biotechnology companies, Isis Pharmaceuticals Inc. and TargeGen Inc., will test potential drugs for the treatment of age-related macular degeneration (AMD). The companies decided to go through with the test despite the U.S. Food and Drug Administration's approval of competitor Genentech Inc.'s AMD drug, Lucentis.
- Subjects :
- BIOTECHNOLOGY industries
RETINAL degeneration
Subjects
Details
- Language :
- English
- ISSN :
- 87506890
- Volume :
- 27
- Issue :
- 29
- Database :
- Complementary Index
- Journal :
- San Diego Business Journal
- Publication Type :
- News
- Accession number :
- 21833648